Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Amsterdam Molecular Therapeutics provides update on Glybera MAA

Aug. 23, 2010

GCC-2680 shows promise as obesity therapeutic based on preclinical data

Aug. 23, 2010

Kalypsys claims new GPR119 receptor agonists

Aug. 23, 2010

Repros seeks meeting with FDA to discuss phase III Androxal protocol

Aug. 19, 2010

Depomed to begin phase III trial of Serada for menopausal hot flashes

Aug. 18, 2010

BioMarin to evaluate neuropsychiatric effects of Kuvan in phase IIIb trial in PKU

Aug. 18, 2010

Medtronic complements bone healing portfolio with Osteotech acquisition

Aug. 18, 2010

LIPO-102 reduces abdominal fat in phase IIa study

Aug. 17, 2010

FDA approves ella tablets for emergency contraception

Aug. 17, 2010

FDA grants orphan status to becaplermin in osteochondritis dissecans

Aug. 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...